1010 related articles for article (PubMed ID: 18410414)
21. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
Clarke LE; Bayerl MG; Bruggeman RD; Mauger D; Ioffreda MD; Abou-Elella A; Helm KF
Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797
[TBL] [Abstract][Full Text] [Related]
22. The role of p53 and anaplastic lymphoma kinase genes in the progression of cutaneous CD30(+) lymphoproliferative diseases.
Kapur S; Tiemann M; Menke MA; Schubert C; Parwaresch R
Indian J Med Res; 2005 Jan; 121(1):46-54. PubMed ID: 15713979
[TBL] [Abstract][Full Text] [Related]
23. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
[TBL] [Abstract][Full Text] [Related]
24. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.
Herbst H; Sander C; Tronnier M; Kutzner H; Hügel H; Kaudewitz P
Br J Dermatol; 1997 Nov; 137(5):680-6. PubMed ID: 9415224
[TBL] [Abstract][Full Text] [Related]
25. CD30-positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: a report of two cases and analysis of CD30 expression.
Gill K; Ariyan C; Wang X; Brady MS; Pulitzer M
J Surg Oncol; 2014 Sep; 110(3):258-64. PubMed ID: 24891295
[TBL] [Abstract][Full Text] [Related]
26. Clusterin expression correlates with stage and presence of large cells in mycosis fungoides.
Chandra P; Plaza JA; Zuo Z; Diwan AH; Koeppen H; Duvic M; Medeiros LJ; Prieto VG
Am J Clin Pathol; 2009 Apr; 131(4):511-5. PubMed ID: 19289586
[TBL] [Abstract][Full Text] [Related]
27. CD30
Sauder MB; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2017 Apr; 31(2):317-334. PubMed ID: 28340881
[TBL] [Abstract][Full Text] [Related]
28. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
[TBL] [Abstract][Full Text] [Related]
29. Intralymphatic Spread Is a Common Finding in Cutaneous CD30+ Lymphoproliferative Disorders.
Ferrara G; Ena L; Cota C; Cerroni L
Am J Surg Pathol; 2015 Nov; 39(11):1511-7. PubMed ID: 26371781
[TBL] [Abstract][Full Text] [Related]
30. Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis.
Marschalkó M; Gyöngyösi N; Noll J; Károlyi Z; Wikonkál N; Hársing J; Kuroli E; Csomor J; Matolcsy A; Sarolta K; Szepesi Á
J Cutan Pathol; 2016 Nov; 43(11):963-973. PubMed ID: 27461449
[TBL] [Abstract][Full Text] [Related]
31. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
[TBL] [Abstract][Full Text] [Related]
32. Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.
Abdulla FR; Zhang W; Wu X; Honda K; Qin H; Cho H; Querfeld C; Zain J; Rosen ST; Chan WC; Parekh V; Song JY
JID Innov; 2022 Jan; 2(1):100068. PubMed ID: 34977845
[TBL] [Abstract][Full Text] [Related]
33. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
Kikuchi A; Nishikawa T
Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
[TBL] [Abstract][Full Text] [Related]
34. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
Kadin ME
Oncology (Williston Park); 2009 Nov; 23(13):1158-64. PubMed ID: 20043465
[TBL] [Abstract][Full Text] [Related]
35. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
[TBL] [Abstract][Full Text] [Related]
37. CD8+ lymphomatoid papulosis and its differential diagnosis.
Magro CM; Crowson AN; Morrison C; Merati K; Porcu P; Wright ED
Am J Clin Pathol; 2006 Apr; 125(4):490-501. PubMed ID: 16627259
[TBL] [Abstract][Full Text] [Related]
38. Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin.
Werner B; Massone C; Kerl H; Cerroni L
J Cutan Pathol; 2008 Dec; 35(12):1100-7. PubMed ID: 18616762
[TBL] [Abstract][Full Text] [Related]
39. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis.
McQuitty E; Curry JL; Tetzlaff MT; Prieto VG; Duvic M; Torres-Cabala C
J Cutan Pathol; 2014 Feb; 41(2):88-100. PubMed ID: 24118002
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of TRAF1 aids in the distinction of cutaneous CD30-positive lymphoproliferations.
Assaf C; Hirsch B; Wagner F; Lucka L; Grünbaum M; Gellrich S; Lukowsky A; Sterry W; Stein H; Dürkop H
J Invest Dermatol; 2007 Aug; 127(8):1898-904. PubMed ID: 17392826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
